| Related Articles |
Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML.
Nat Rev Clin Oncol. 2017 Feb 07;:
Authors: Hughes TP, Ross DM
PMID: 28169304 [PubMed - as supplied by publisher]
http://ift.tt/2kRC04w
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου